SI Group, Inc. Overview
SI Group is a mid-sized, private, global maker of performance additives and chemical intermediates. Its core is antioxidant and stabilizer chemistry: phenolic, aminic and phosphite antioxidants, UV stabilizers and coupling agents. It is backward-integrated into alkylphenols and alkylated cresols. The company also has a long-established franchise in phenolic resins for tires and rubber (tackifying, reinforcing, bonding and curing resins), resins and intermediates for oilfield production chemistry, and specialty intermediates such as 4,4'-biphenol. The current company was formed in 2018 by combining legacy SI Group (Schenectady) with SK Capital's Addivant (the former Chemtura antioxidants business). Its stated vision is to become "the global performance additives powerhouse". Since 2021 it has divested non-core resins, closed high-cost Asian plants, exited ibuprofen and gone through two balance-sheet restructurings (2024 and 2025). After cutting net debt by about USD 1.7B in December 2025, it is now trying to return to growth through regional partnerships (Azelis, Dingjide, Shengxiao), new innovation centres and pricing actions.
Company's own description. SI Group describes itself as a global leader in performance additives, process solutions and chemical intermediates (2026 boilerplate). Its chemistries improve the quality and performance of industrial and consumer goods in plastics, rubber and adhesives, fuels, lubricants, coatings and oilfield. Before 2026 the boilerplate also named "pharmaceuticals" and "active pharmaceutical ingredients". That wording disappears from 2026 releases, though it remains in the website metadata. Read together, this suggests the company is de-emphasizing APIs after it ended ibuprofen production in 2024. [siigroup.com/about; PRs Dec 2025 vs Mar–Jul 2026]
Five "Key Strategic Markets" (the company's own organizing framework) [siigroup.com/about, 2026]:
-
Core Solutions: chemical intermediates for industrial uses and other end markets.
-
Fuel, Lubricants & Coatings: antioxidants, intermediates and specialty additives for coatings, fuels, greases and lubricants.
-
Oilfield: resins and intermediates for oilfield production chemistry.
-
Plastics: antioxidants, non-dust blends and additives for plastics stabilization, compounding and circularity.
-
Rubber & Adhesives: resins and additives for tires, technical rubber goods and adhesives.
Business model. This is an almost entirely product-based model. SI Group manufactures and sells chemicals on volume contracts and spot orders, directly to large accounts and through distributors in other regions (Brenntag in EMEA since 2005; Azelis added for EMEA plastics additives from 1 January 2026). Service revenue (technical service, application development at six innovation centres) is bundled into product pricing and not monetized separately. No subscription or licensing revenue is disclosed. Two exceptions involve technology deals: in 2021 SI Group licensed industrial-resins technology to ASK Chemicals, and in 2026 it contributed proprietary biphenol technology to the Shengnova JV. Toll and co-production arrangements, such as the one with Dingjide in China, are increasingly part of the supply model. [Company PRs 2021, 2024, 2025, 2026]
Revenue model mix (estimate of character, not disclosed numerically).
Value-chain position. SI Group is a mid-stream specialty producer. It buys petrochemical building blocks (phenol, isobutylene and other olefins, cresols, phosphorus chemicals, amines). It converts them into alkylphenol intermediates, then into higher-value antioxidants and resins, which it sells to compounders, polymer producers, tire makers, lubricant and fuel additive blenders, and oilfield service and chemical formulators. The 2018 SK Capital rationale described the combined company as backward-integrated into key chemical intermediates. [SK Capital PR, 15 Oct 2018]
Customer types. Customers include polyolefin and engineering-polymer producers and compounders; tire and technical-rubber manufacturers; adhesive formulators; lubricant, grease and fuel-additive companies; oilfield chemical formulators; coatings producers; and, historically, pharmaceutical formulators (ibuprofen, propofol).
End-markets served. The website lists agriculture, automotive, building and construction, chemical intermediates, coatings, consumer goods, elastomers, electronics, fuel additives, furniture, grease additives, health and nutrition, lubricant additives, metal processing, oil and gas, oilfield chemicals, packaging, personal care, recycling, textiles, and tire and rubber. [siigroup.com navigation, 2026]
Independent characterization. SI Group is a sub-scale but well-franchised antioxidant and stabilizer house. Its competitors are far larger (BASF, Songwon, Adeka) or low-cost Chinese producers (e.g., Rianlon). Its differentiation rests on four things: (i) integration into alkylphenols, where it claims market leadership; (ii) legacy brands from Addivant/Chemtura (NAUGARD, ANOX, LOWINOX, WESTON) and Albemarle (ETHANOX); (iii) a strong niche in tire phenolic resins; and (iv) niche specialty molecules (4,4'-biphenol). Since 2018, the investment case has been dominated by the leverage taken on in the SK Capital buyout. The 2024 and 2025 restructurings imply that operating cash flow could not service that debt during the 2023–2025 chemicals downturn.
Strategy
Stated strategy themes (company website, 2026; paraphrased):
Vision: become the global performance additives powerhouse (set in 2019).
Strategic pillars: anticipate customer problems and solve them with innovative chemistry; use the breadth of the global portfolio; run as one global organization with high business agility; execute "The Perfect Order" every time.
Mission: innovate and drive change to create value, with emphasis on safety, chemistry, sustainability and results.
Values: Results Matter; Reach Beyond Your Possible; Embrace the Grit; Lean In; Captivate Our Customers; Better Every Day; Do the Right Thing.
Strategic initiatives in the last 24 months (Oct 2024 – Oct 2026):
Medium-term financial targets and guidance: none disclosed.
Products & Services
Detailed specifications, pricing and launch years are generally NPD. SI Group sells on contract and quotation and does not publish list prices. Where a function is inferred from the chemistry class rather than stated by the company, this is noted.
Plastics
| Brand / line | Description | Key capabilities | Target customer | Launch / latest | Pricing |
|---|---|---|---|---|---|
| ANOX™ | Hindered phenolic primary antioxidants (legacy Addivant/Chemtura brand) | Long-term thermal stabilization of polyolefins, styrenics, engineering plastics | Polymer producers, compounders | Legacy; current | NPD |
| LOWINOX™ | Specialty phenolic antioxidants (legacy Addivant) | Low-colour and low-volatility stabilization; also used in elastomers | Polymer, elastomer, adhesive producers | Legacy; current | NPD |
| WESTON™ (incl. WESTON 705) | Phosphite secondary antioxidants. WESTON 705 is a next-generation, nonylphenol-free liquid phosphite for plastics and elastomers | Processing stabilization; removes nonylphenol concerns for regulated applications; capacity tripled within two years of launch (2014–2016) | Polyolefin, PVC, elastomer producers; packaging | 2014–2016 launch; showcased at K 2025 | NPD |
| ETHANOX™ | Phenolic antioxidants (ex-Albemarle, acquired 2014) | Stabilization for polymers, fuels and lubricants | Polymer and fuel/lube customers | Acquired 2014 | NPD |
| POLYBOND™ | Chemically modified (grafted) polyolefin coupling agents and compatibilizers (legacy Addivant) | Improve filler and glass-fibre adhesion and blend compatibility | Compounders, automotive plastics | Legacy; current | NPD |
| EVERCYCLE™ | Additive platform for recycled plastics and circularity | Restabilizes and upgrades recycled polyolefins (e.g., recycled PP) | Recyclers, packaging and consumer-goods converters | Launched 2022 | NPD |
| UV Light Stabilizers | UV absorbers and stabilizers (product technology category) | Weathering protection | Outdoor and automotive plastics | Current | NPD |
| Non-dust blends | Pre-blended, low-dust additive packages | Handling safety and dosing accuracy | Polymer producers | Current | NPD |
| PFAS-free and "Arvin-free" technologies | New solutions presented at K 2025 for automotive, packaging and consumer applications | Regulatory-driven substitution | Automotive and packaging OEMs | Presented Oct 2025 | NPD |
Rubber & Adhesives
| Brand / line | Description | Key capabilities | Target customer | Launch / latest | Pricing |
|---|---|---|---|---|---|
| Tackifying resins (alkylphenol-formaldehyde Novolac) | Provide building tack in green-tire assembly | Lote, India capacity expanded ~75% (2021–2022) | Tire makers (especially India/APAC) | Expansion completed 2022 | NPD |
| Reinforcing resins | Phenolic resins that raise compound hardness and modulus | Tread, bead and apex compounds | Tire and technical rubber goods | Current | NPD |
| Bonding resins | Rubber-to-cord adhesion systems | Steel and textile cord adhesion | Tire makers | Current | NPD |
| Curing resins / curing accelerators | Phenolic resin cure systems (e.g., for butyl bladders) | Heat-resistant crosslinking | Tire bladder and technical rubber makers | Current | NPD |
| NAUGARD™ antidegradants | Aminic and phenolic antioxidants and antiozonants (legacy Chemtura/Addivant) | Protection against heat, oxygen and ozone | Tire and rubber makers; also lubricants | Legacy; current | NPD |
| NAUGARD BIO-XL | Rubber additive that does not release the harmful nitrosamines listed in TRGS 552 | Supports nitrosamine compliance in rubber | Technical rubber, EU customers | Showcased K 2025 | NPD |
| Adhesive tackifiers | Phenolic tackifiers for adhesives | Hot-melt and solvent-borne adhesive tack | Adhesive formulators | Current | NPD |
Fuel, Lubricants & Coatings
| Brand / line | Description | Key capabilities | Target customer | Pricing |
|---|---|---|---|---|
| Lubricant and grease antioxidants (aminic, NAUGARD family; phenolic, ETHANOX/ANOX) | Oxidation inhibitors for engine oils, industrial lubricants and greases | Extend drain intervals and thermal stability | Lubricant additive and oil companies | NPD |
| Alkylated phenols for lubricant additives | Intermediates for detergents and antioxidants used in automotive engine oils | Backward-integrated alkylphenol supply | Lube additive majors | NPD |
| Fuel antioxidants | Hindered-phenol stabilizers for fuels and biofuels | Gum and peroxide prevention | Refiners, biofuel producers | NPD |
| Can-coatings resins / intermediates | Phenolic resins for internal can coatings (website application category) | Food-contact coatings | Coatings formulators | NPD |
Oilfield
| Brand / line | Description | Target customer | Pricing |
|---|---|---|---|
| Asphaltene inhibitors (product technology) | Resins that prevent asphaltene deposition in production systems | Oilfield chemical formulators | NPD |
| Demulsifier / production-chemistry resin intermediates | Alkylphenol-formaldehyde resin intermediates for demulsifiers | Oilfield service companies | NPD |
| ETHAFLOW™, CERIFLOW™ | Branded oilfield and flow-related product lines in the company catalogue. | Oilfield formulators | NPD |
Core Solutions (Chemical Intermediates)
| Product | Description | Site / note | Pricing |
|---|---|---|---|
| Alkylphenol intermediates (e.g., tert-butyl phenols) | Building blocks for antioxidants, resins, UV absorbers and lube additives. SI Group claims market leadership | Supplied from Europe and the Americas after the Singapore closure | NPD |
| Specialty alkylphenols and alkyl cresols | Intermediates for high-performance antioxidants | Pratteln, Switzerland (since 1994 acquisition) | NPD |
| 4,4'-Biphenol | Monomer for liquid crystal polymers (LCP), polyphenylsulfone (PPSU) and other high-performance materials | Newport, Tennessee; and, from 2026, the Shengnova JV in Sichuan, China | NPD |
| Phenolic resins (product technology) | Industrial phenolic resins retained in the U.S. and China after the 2021 sale | U.S. and China | NPD |
Pharmaceuticals (legacy / contracting)
| Product | Status | Source |
|---|---|---|
| Ibuprofen API (bulk, with DMF/CEP/JDMF per directory) | Acquired from Albemarle in 2014, which made SI Group a top-3 global supplier at the time. Production at Orangeburg, SC ended in 2024 (74 jobs; WARN notice 26 Jun 2024). The company cited being unable to supply ibuprofen competitively | Albemarle/SI PRs 2014; WARN; Times and Democrat Jul 2024 |
| Propofol API | Acquired 2014. Current status NPD. Directory listings persist | PharmaCompass |
| Ibuprofen sodium | Listed in directory; current status NPD | PharmaCompass |
Services
| Service | Description |
|---|---|
| Application development and technical service | Delivered through six innovation centres: Houston TX; Rotterdam Junction NY; Morgantown WV; Four Ashes UK; Lote India; Shanghai China. The Four Ashes centre focuses on plastics and rubber application development and analytical characterization |
| Supply-security model | Multi-site supply, co-production (Dingjide) and JV supply (Shengnova). The company also commits to "The Perfect Order" service standard |
Financial Narrative
Disclosure status. SI Group files no public financial statements. Its debt is privately placed and syndicated (term loans and formerly unsecured notes), and the restructuring documents are not public. Every line in the requested income statement, balance sheet, cash flow and ratio tables is therefore not publicly disclosed for FY2021–FY2025. Blank cells in the chartable tables below mean NPD and are not zeros. The only quantitative disclosures available are company-stated scale indicators and capital-structure facts.
Company-stated scale indicators (chartable)
Sources and notes:
-
FY2018 sales are the sum of pre-merger SI Group (~USD 1B) and Addivant (~USD 500M), per ERJ, Oct 2018.
-
FY2019 and FY2020 figures come from company boilerplates of Aug 2019 and Dec 2020 ("approximately $2 billion in annual sales"; "more than 3,000 employees"; "more than 30 facilities"). The 2019 figure cites "more than 30 facilities on five continents".
-
FY2021 figures are from the Nov 2021 PR (21 facilities, four continents, 90 countries, ~2,300 employees).
-
FY2022 facility count is from the Aug 2022 Baytown Sun (20 facilities).
-
FY2024 figures are from the Feb 2024 PR (20 facilities, three continents, 80 countries, ~2,000 employees).
-
FY2025 figures are from the Dec 2025 PR (18 facilities, ~1,600 employees, 80 countries).
-
FY2026 figures are from the Mar–Jul 2026 PRs (~1,500 employees, 18 facilities, 80+ countries).
-
"3000" is a floor ("more than 3,000"). Revenue after FY2020 is not disclosed.
Income statement (chartable; all NPD)
EPS and DPS do not apply to a privately held company with no public share count. Revenue CAGR FY2021–FY2025 is NPD.
Commentary on trends, inflections and drivers
Scale contraction (2019 → 2026). The disclosed indicators show a business that has shrunk deliberately and under pressure. Headcount fell about 50% (from more than 3,000 to about 1,500). Plant count fell about 40% (from 30+ to 18). The country reach of the customer base dropped from about 90 to about 80. Part of this was strategic pruning:
-
the industrial resins sale to ASK Chemicals in 2021;
-
the Navi Mumbai site sale in 2022;
-
the move to an asset-light approach in China through the Dingjide co-production deal in 2024.
Part was retreat from uncompetitive positions:
-
ibuprofen at Orangeburg (2024);
-
Singapore alkylphenols, where the company cited regional supply-demand shifts and high Singapore costs (2024–2025).
The ~USD 2B revenue claimed in 2019–2020 almost certainly included the businesses since divested. Current revenue is not disclosed and should not be assumed to be USD 2B.
Leverage as the defining financial variable. SK Capital's 2018 buyout used committed debt financing (SK Capital PR, Oct 2018). By 2024 the company needed a liability-management exercise: an exchange extending maturities to 2028 plus USD 150M of sponsor equity. Fifteen months later a second, deeper recapitalization removed about USD 1.7B of net debt, more than 80% of the total. That sequence implies three things. Pre-2025 net debt was roughly USD 2B. EBITDA during the 2023–2025 chemicals destocking cycle was too low to service it. Most of the economic value transferred to lenders, and SK Capital's equity was very likely impaired; the release mentions advisers to "current equity holders" and a new ownership group, so this is a reasonable inference.
Pricing as a recurring lever. The company used broad price increases repeatedly:
-
rubber and adhesive additives up 15–20% (Dec 2020) and up to 25% (Nov 2021);
-
plastics additives up to 20% (Apr 2021);
-
a freight surcharge-type increase (Feb 2024);
-
a portfolio-wide increase tied to Middle East geopolitical, energy and logistics disruption (Mar 2026).
Post-recapitalization inflection (2026). After the restructuring the balance sheet is much lighter, which frees management to invest. The 2026 releases are growth-oriented: a JV, a centennial reinvestment pledge at Pratteln, and a strategic-marketing elevation. Profitability data needed to confirm an operating turnaround remain NPD.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Strategic Market Details
| Strategic market (company-defined) | Contents | Representative products | Segment revenue (3 yrs) | Segment profit / margin | % of total |
|---|---|---|---|---|---|
Plastics | Polymer stabilization, compounding, circularity | ANOX, LOWINOX, WESTON, ULTRANOX-type phosphites, POLYBOND coupling agents, EVERCYCLE, UV light stabilizers, non-dust blends | NPD | NPD | NPD |
Rubber & Adhesives | Tire and technical rubber resins, antidegradants, adhesive tackifiers | Tackifying, reinforcing, bonding and curing phenolic resins; NAUGARD antidegradants; NAUGARD BIO-XL | NPD | NPD | NPD |
Fuel, Lubricants & Coatings | Antioxidants, intermediates and specialty additives | ETHANOX, NAUGARD (aminic) lubricant antioxidants, alkylphenol intermediates, can-coating resins | NPD | NPD | NPD |
Oilfield | Production-chemistry resins and intermediates | Asphaltene inhibitors, demulsifier resin intermediates, ETHAFLOW / CERIFLOW-branded lines (function per company catalogue) | NPD | NPD | NPD |
Core Solutions | Chemical intermediates for industrial uses | Alkylphenols (e.g., tert-butyl phenols), alkyl cresols, 4,4'-biphenol, phenolic resins | NPD | NPD | NPD |
Key Financials and Operating Metrics (count)
| Metric | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|
Annual sales, company-stated approx. (USD Mn) | 1,500 | 2,000 | 2,000 | — | — | — | — | — |
Employees, approx. (count) | 3,000 | 3,000 | 3,000 | 2,300 | — | 2,000 | 1,600 | 1,500 |
Manufacturing facilities (count) | 30 | 30 | 30 | 21 | 20 | 20 | 18 | 18 |
Countries with customers (count) | — | 90 | 90 | 90 | — | 80 | 80 | 80 |
Financial Analysis
| Item | Detail | Source |
|---|---|---|
Sep–Oct 2024 exchange | ~100% of first-lien lenders and 89% of unsecured noteholders participated at initial settlement (30 Sep 2024) | Company PR 2 Oct 2024; Latham 8 Oct 2024 |
Maturities after 2024 exchange | Extended to 2028 | Company PR Oct 2024 |
Revolver (2024) | New USD 218M revolving credit facility with "full access" | Company PR Oct 2024 |
Sponsor support (2024) | USD 150M new money from SK Capital and affiliates to bolster liquidity and repay debt | Company PR Oct 2024 |
Interest (2024) | Overall reduction in annual cash interest expense; amount NPD | Company PR Oct 2024 |
Dec 2025 recapitalization | Net indebtedness reduced by ~USD 1.7B (described as over 80%); revolver amended | Company PR 23/24 Dec 2025 |
New capital (2025) | USD 150M junior capital from the new institutional ownership group | Company PR Dec 2025 |
Implied pre-recap net debt | If USD 1.7B equals "over 80%", pre-recap net debt was below ~USD 2.1B and post-recap net debt below ~USD 0.4B. This is analyst derivation, not disclosed | Derived |
Lender group advisers (2025) | Akin Gump (legal) and Lazard (banker) to an ad hoc group of second-out term-loan lenders. The term "second-out" implies a first-out/second-out structure created in 2024 | Company PR Dec 2025 |
Company advisers (2025) | Latham & Watkins (legal), PJT Partners (banker), AlixPartners (financial). Baker Botts advised existing equity holders | Company PR Dec 2025 |
Holding structure | New holding structure built through Luxembourg | Loyens & Loeff 2025/26 |
Key Financials
| Metric | FY2024 | FY2025 |
|---|---|---|
Sponsor / new-owner capital injected (USD Mn) | 150 | 150 |
Region Overview
| Region | Direction (inferred) | Evidence | Source |
|---|---|---|---|
North America | Core and stable; HQ and most plants | 7 U.S. manufacturing sites, HQ and two innovation centres in Texas; ibuprofen exit at Orangeburg (2024) | siigroup.com/locations; WARN 2024 |
Europe | Investment and distribution expansion | European Innovation Centre opened Oct 2025; Azelis added as EMEA plastics-additive distributor alongside Brenntag from 1 Jan 2026; Pratteln centennial with reinvestment commitment (May 2026) | Company PRs 2025–26 |
China / East Asia | Asset-light restructuring, then selective re-entry via JV | Jinshan closure (2024) with Dingjide co-production; Shengnova biphenol JV (Jun 2026) targeting electronics, automotive and medical demand | Company PRs 2024, 2026 |
Southeast Asia | Declining | Singapore alkylphenol plant closure (H2 2025) | Company PR Sep 2024 |
India | Growth hub for tire resins | Lote tackifier capacity +75% (2021–22); Lote innovation centre; Navi Mumbai plant sold (2022) but commercial staff kept | Company PRs 2021–22, 2025 |
Latin America | Reduced | Rio Claro industrial-resin assets sold to ASK (2021). Related businesses retained; the Rio Claro address now maps to ASK Crios premises, suggesting shared-site arrangements (inference) | Company PR Nov 2021; siigroup.com/locations |
Africa | Exited (manufacturing) | Johannesburg site sold to ASK (2021) | Company PR Nov 2021 |
Middle East | JV presence | Gulf Stabilizers Industries (Saudi Arabia) JV since 2000 | siigroup.com/about |
Capital Markets
| Item | Status |
|---|---|
Share price performance (1/3/5-year) | Not applicable (no listed equity) |
Valuation multiples (P/E, EV/EBITDA, EV/Sales, P/B) | Not applicable / NPD |
Peer multiples | Not computed (no SI Group base to compare) |
Analyst consensus | None (no equity coverage) |
Dividend history / policy | NPD. Private; no public dividend policy |
Credit ratings (Moody's / S&P / Fitch) | Under S&P criteria, distressed exchanges such as the 2024 transaction are typically treated as selective default, absent adequate compensation. That is a general criteria point, not a confirmed SI Group action |
Debt maturity profile | After Sep 2024: maturities extended to 2028, USD 218M revolver. After Dec 2025: revolver amended; residual debt quantum and maturity ladder NPD |
Valuation reference | CB Insights estimates the 2018 SK Capital acquisition at USD 1.5–2.5B (estimate) |
Analyst Conclusions
Management guidance: none published. The qualitative direction from 2026 communications is growth investment, operational improvement and customer focus, enabled by the December 2025 recapitalization.
Consensus growth expectations: none exist (no coverage).
Bull case
-
Balance-sheet reset: cutting more than 80% of net debt removes the interest drag that forced two restructurings. Even modest EBITDA can now produce free cash flow for reinvestment (PR Dec 2025).
-
Higher-growth niches: biphenol for LCP/PPSU (Shengnova JV), circular-plastics additives (EVERCYCLE) and regulatory-substitution products give SI Group exposure beyond commodity antioxidants (PRs 2025–26).
-
Lean footprint: after the Jinshan, Singapore and ibuprofen exits, the remaining 18-site network is concentrated in competitive positions (alkylphenol integration in the U.S. and Europe, the India tire-resin hub), which should lift margins as volumes recover.
Bear case
-
Scale erosion: headcount halved and plant count down about 40% since 2019–20. Revenue is undisclosed and may be well below the old ~USD 2B. The company may lack the scale to compete with BASF, Songwon and Chinese producers.
-
Re-default risk: industry data show high re-default rates after distressed exchanges. The amended revolver and any remaining debt still depend on a cyclical chemicals recovery that had not been evident through 2025.
-
Ownership uncertainty: an unnamed, credit-oriented owner group (AIP Credit Opportunities is inferred) may favour a near-term exit or carve-ups over long-term building. The CCO departure and new ELT appointments add execution risk.
Key catalysts and monitorables (next 12 months)
-
Any disclosure of owner identities, board chair appointment, or a sale or carve-out process.
-
Start-up and offtake of the Shengnova biphenol JV; continued Newport production.
-
Azelis channel performance in EMEA plastics additives during 2026.
-
Further price actions, or reversals, as Middle East logistics and energy conditions evolve.
-
Credit-agency actions on the post-recapitalization structure.
-
New plant closures or reinvestments (Pratteln commitment; Orangeburg site use after ibuprofen).
-
2026 EcoVadis follow-through and quantified ESG targets.
Analyst verdict
SI Group is no longer the ~USD 2B, 30-plant, 3,000-person conglomerate of specialty chemistries that SK Capital assembled in 2018. Since 2021 it has sold its industrial-resins business, its Navi Mumbai plant and its upstate New York campus. It has closed or exited Jinshan, Singapore and Orangeburg ibuprofen. It has gone through two restructurings in fifteen months, ending in December 2025 with lenders and a new institutional ownership group taking control and about USD 1.7B of net debt written away. The company left behind is smaller (about 1,500 employees and 18 plants) and much less leveraged, and its strategy is more focused. It is built around antioxidants and stabilizers backed by in-house alkylphenols, phenolic tire resins centred on India, and selected high-performance intermediates such as biphenol.
The 2026 newsflow is notably constructive for a company only months out of a restructuring. It includes a China JV, an EMEA distribution expansion, an EcoVadis upgrade, a centennial reinvestment pledge and a commercial-leadership promotion. This reads as a management team that now has the financial room to play offence. The core problem has not changed, however. In its largest product categories SI Group remains a mid-tier player against far larger and lower-cost rivals. Without published financials, investors and counterparties cannot test whether margins have recovered from the 2023–2025 trough.
Our assessment is cautiously constructive on survival and stability, neutral on value creation. Restructuring risk has fallen sharply in the near term. The medium-term thesis now depends on proving that the slimmed portfolio can grow profitably, first in biphenol, circularity additives and India tire resins. Counterparties should seek owner-level transparency and current credit ratings before extending material exposure. Potential acquirers should treat SI Group as a likely candidate for an owner-led sale or asset-by-asset monetization within the typical credit-fund holding period.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title | Tenure | Prior roles | Education | Age | Compensation |
|---|---|---|---|---|---|---|
David Bradley | President & CEO; director | Since 18 Mar 2019 | President & CEO, Nexeo Solutions; ~7 years at Kraton Performance Polymers incl. COO; career began at GE Plastics. Outside boards: Ecovyst, South Texas Truck Centers | B.S. Chemical Engineering, University of Louisville | NPD | NPD (no proxy) |
Rustom Jilla | SVP & CFO | Since 5 Jan 2022 | CFO of IFF (through the DuPont N&B merger); CFO roles at MSC Industrial Direct, Dematic Group, Ansell | NPD | NPD | NPD |
Robert Kaiser | SVP, Strategic Marketing (joined ELT) | Promoted 13 Jul 2026; with SI Group since 2014 | VP Strategic Marketing & MD EMEA; VP Rubber & Adhesives Solutions; earlier AkzoNobel and Arizona Chemical (now Kraton) | MBA, Ruhr University Bochum | NPD | NPD |
Brooke Manrique | SVP, Human Resources & Communications | In role by 2022 | NPD | NPD | NPD | NPD |
Paul Tilley | SVP, Business Development | NPD | NPD | NPD | NPD | NPD |
Mike Farnell | SVP, General Counsel & Chief Sustainability Officer | In role by Mar 2026 (not shown on the ELT web page) | NPD | NPD | NPD | NPD |
Board of Directors
| Director | Background | Other boards | Independence (assessed) |
|---|---|---|---|
Shawn Abrams | Former President, Catalyst Technologies, W.R. Grace | Clean Chemistry; PQ Corporation; Savillex | Non-executive |
Luis Fernandez-Moreno | Former Interim President & CEO, Ingevity | HASA Pool; Huber Engineered Materials; Ingevity; Select Water Solutions | Non-executive |
Daryl Roberts | Former SVP, Chief Operations & Engineering Officer, DuPont | AdvanSix; American Electric Power | Non-executive |
Jan Trnka-Amrhein | Partner, Credit Opportunities, American Industrial Partners | Apex Tool Group; Envivia Biomass | Owner representative (likely) |
David Bradley | President & CEO, SI Group | Ecovyst; South Texas Truck Centers | Executive |
Board & Management Changes
| Date | Change | Context | Source |
|---|---|---|---|
May 2013 | Frank Bozich succeeds Stephen Large as CEO | Growth/M&A era (Albemarle deal) | PR 6 May 2013 |
Oct 2018 | Post-merger leadership: Frank Bozich (CEO) and John Steitz (CEO, Additives segment) | SK Capital merger with Addivant | SK Capital PR 2018 |
Late 2018 – Mar 2019 | David Mezzanotte (SK Capital) interim CEO | Bozich departure; search | PR Mar 2019 |
18 Mar 2019 | David Bradley CEO | Transformation programme | PR Mar 2019 |
5 Jan 2022 | Rustom Jilla replaces Patrick Weinberg as CFO | Pre-refinancing finance upgrade | PR Jan 2022 |
| 2024 | Joey Gullion serving as SVP & Chief Commercial Officer | Led China and Singapore footprint moves | PRs Feb & Sep 2024 |
By 2026 | Gullion no longer listed on the ELT; departure date NPD | Commercial leadership re-cut | siigroup.com/about |
Dec 2025 | Board reconstituted under new ownership (inferred) | Recapitalization | siigroup.com/about |
13 Jul 2026 | Robert Kaiser promoted to SVP Strategic Marketing, joins ELT | Commercial growth strategy | PR 13 Jul 2026 |
Major Shareholders
| Holder | Stake | Note |
|---|---|---|
New institutional ownership group (members not disclosed) | Controlling (inferred) | USD 150M junior capital, Dec 2025 |
American Industrial Partners (Credit Opportunities) | NPD; unconfirmed | Inferred from board seat |
SK Capital Partners and affiliates | Residual stake, if any, NPD | Sponsor from 2018 to Dec 2025 |
Insider / management ownership | NPD | — |
Competitive Landscape
Peer Comparison
| SI Group market | Named competitors (minimum 8–10 overall) |
|---|---|
Plastics antioxidants and stabilizers | BASF (Irganox/Irgafos/Tinuvin); Songwon Industrial (Korea); Adeka (Japan); Rianlon (China); Clariant (additives); Dover Chemical (phosphites; ICC Industries); Sumitomo Chemical |
Rubber chemicals and tire resins | Lanxess (rubber additives); Flexsys (ex-Eastman tire additives); Sino Legend (China, phenolic tackifier resins); Sumitomo Bakelite; Kumho Petrochemical; Struktol |
Lubricant and fuel antioxidants | BASF; Lanxess; Vanderbilt Chemicals; Lubrizol and Afton (captive and merchant additive majors) |
Alkylphenols and intermediates | Dover Chemical; Chinese alkylphenol producers; integrated phenol producers (identities and shares NPD) |
Oilfield production chemicals (resin intermediates) | Formulators such as SLB/ChampionX and Baker Hughes, plus merchant resin suppliers (overlap partial) |
Biphenol | Shengxiao (now JV partner); other Chinese and Japanese producers (NPD) |
Peer Comparison FY2024
| Company | Ownership | Latest revenue (FY, currency) | Growth | Margins | R&D intensity | Note |
|---|---|---|---|---|---|---|
SI Group | Private | NPD (~USD 2B claimed for 2019–2020, before divestitures) | NPD | NPD | NPD | 18 plants; ~1,500 staff (2026) |
BASF SE | Listed (XETRA: BAS) | ~EUR 65.3B, group (FY2024, annual report). | See filings | See filings | See filings | Global leader in polymer additives |
LANXESS AG | Listed (XETRA: LXS) | ~EUR 6.4B, group (FY2024, annual report) | See filings | See filings | See filings | Rubber chemicals and lubricant additives overlap |
Songwon Industrial | Listed (KRX) | — | — | — | — | No. |
Recent Developments
SI Group is a private company with a low disclosure cadence. To give context, the register is extended back to February 2024.
Not identified in public sources during the window: * guidance revisions, contract wins, litigation or regulatory actions.



